BL-M05D1

· SystImmune Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BL-M05D1, covering 2025-06-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors [Phase 1]

See pricing